What does BioCryst Pharmaceuticals, Inc. do?
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB,…
What is BioCryst Pharmaceuticals, Inc.'s P/E and P/B ratio?
BioCryst Pharmaceuticals, Inc. has a P/E ratio of -5.6 and a P/B ratio of -4.38.
What is BioCryst Pharmaceuticals, Inc.'s debt-to-equity ratio?
BioCryst Pharmaceuticals, Inc. has a debt-to-equity ratio of -3.68.
How much does BioCryst Pharmaceuticals, Inc. owe compared with what it owns?
BioCryst Pharmaceuticals, Inc. owes $1.81 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is BioCryst Pharmaceuticals, Inc.'s Positivity rank?
BioCryst Pharmaceuticals, Inc. is ranked #6,562 of 6,774 companies globally and #3,806 of 4,000 in United States on PositoAI, with a Positivity Score of -25,293.
Does BioCryst Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BioCryst Pharmaceuticals, Inc..
Where can I read the latest news about BioCryst Pharmaceuticals, Inc.?
Recent headlines about BioCryst Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does BioCryst Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of BioCryst Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.